Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure-Reference-Cited by-同舟云学术

Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure

Published:2021-03-20 Issue:3 Volume:8 Page:2016-2024
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Arfsten Henrike¹^ORCID,Goliasch Georg¹,Bartko Philipp E.¹,Prausmüller Suriya¹,Spinka Georg¹,Cho Anna¹,Novak Johannes¹,Mascherbauer Julia¹,Haslacher Helmuth²,Strunk Guido³,Hülsmann Martin¹,Pavo Noemi¹

Affiliation:

1. Department of Internal Medicine II, Division of Cardiology Medical University of Vienna Waehringer Guertel 18‐20 Vienna 1090 Austria

2. Department of Medical and Chemical Laboratory Diagnostics Medical University of Vienna Waehringer Guertel 18‐20 Vienna 1090 Austria

3. Complexity Research Schönbrunner Straße 32 Vienna 1050 Austria

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13278

Reference39 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

3. Highlights in heart failure

4. A Test in Context: Neprilysin

5. Proenkephalin in Heart Failure

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous opiates and behavior: 2021;Peptides;2023-06

2. Proenkephalin as a Novel Prognostic Marker in Heart Failure Patients: A Systematic Review and Meta-Analysis;International Journal of Molecular Sciences;2023-03-03